Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of CArdioToxic-related CHest Pain in Cancer Patients Treated With 5-fluorouracil

NCT03486340 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.

NCT NCT03486340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03486340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of CArdioToxic-related CHest Pain in Cancer Patients Treated With 5-fluorouracil
Lead sponsor
Vejle Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 11, 2018
Completion date
June 7, 2024
Enrollment
218 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

5-fluorouracil toxicity, acute coronary syndrome, cardiotoxicity, chemotherapeutic toxicity, chest pain, coronary artery calcification, solid carcinoma